Department of Gastroenterology and Hepatology, Radboudumc, Nijmegen, The Netherlands.
Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands.
J Hepatobiliary Pancreat Sci. 2022 Apr;29(4):479-486. doi: 10.1002/jhbp.1096. Epub 2021 Dec 21.
Acute cholangitis is an infection requiring endoscopic retrograde cholangiopancreatography (ERCP) and antibiotics. Several diagnostic tools help to diagnose cholangitis. Because diagnostic performance of these tools has not been studied and might therefore impose unnecessary ERCPs, we aimed to evaluate this.
We established a nationwide prospective cohort of patients with suspected biliary obstruction who underwent an ERCP. We assessed the diagnostic performance of Tokyo Guidelines (TG18), Dutch Pancreatitis Study Group (DPSG) criteria, and Charcot triad relative to real-world cholangitis as the reference standard.
127 (16%) of 794 patients were diagnosed with real-world cholangitis. Using the TG18, DPSG, and Charcot triad, 345 (44%), 55 (7%), and 66 (8%) patients were defined as having cholangitis, respectively. Sensitivity for TG18 was 82% (95% CI 74-88) and specificity 60% (95% CI 56-63). The sensitivity for DPSG and Charcot was 42% (95% CI 33-51) and 46% (95% CI 38-56), specificity was 99.7% (95% CI 99-100) and 99% (95% CI 98-100), respectively.
TG18 criteria incorrectly diagnoses four out of ten patients with real-world cholangitis, while DPSG and Charcot criteria failed to diagnose more than half of patients. As the cholangitis diagnosis has many consequences for treatment, there is a need for more accurate diagnostic tools or work-up towards ERCP.
急性胆管炎是一种需要进行内镜逆行胰胆管造影术(ERCP)和抗生素治疗的感染。有几种诊断工具可用于诊断胆管炎。由于这些工具的诊断性能尚未得到研究,因此可能会导致不必要的 ERCP,我们旨在对此进行评估。
我们建立了一个全国性的疑似胆道梗阻患者前瞻性队列,这些患者接受了 ERCP 检查。我们评估了东京指南(TG18)、荷兰胰腺炎研究组(DPSG)标准和 Charcot 三联征相对于真实世界胆管炎的诊断性能,将真实世界胆管炎作为参考标准。
在 794 例患者中,有 127 例(16%)被诊断为真实世界胆管炎。使用 TG18、DPSG 和 Charcot 三联征,分别有 345 例(44%)、55 例(7%)和 66 例(8%)患者被定义为患有胆管炎。TG18 的敏感性为 82%(95%CI 74-88),特异性为 60%(95%CI 56-63)。DPSG 和 Charcot 的敏感性分别为 42%(95%CI 33-51)和 46%(95%CI 38-56),特异性分别为 99.7%(95%CI 99-100)和 99%(95%CI 98-100)。
TG18 标准错误地诊断了十分之四的真实世界胆管炎患者,而 DPSG 和 Charcot 标准未能诊断出一半以上的患者。由于胆管炎的诊断对治疗有许多影响,因此需要更准确的诊断工具或进一步进行 ERCP 检查。